Last updated on March 2015

A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients


Brief description of study

The purpose of this study is to obtain information on efficacy, safety and Pharmacokinetics (PK)/Pharmacodynamics (PD) of Hetrombopag over 14 days in Chinese patients with chronic ITP.

Clinical Study Identifier: NCT02403440

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Liang Maozhi

West Hospital, Sichuan University
Chengdu, China
  Connect »